LOTEMAX EY.DRO.SUS 0,5% W/V (5MG/1ML) Grécko - gréčtina - Εθνικός Οργανισμός Φαρμάκων

lotemax ey.dro.sus 0,5% w/v (5mg/1ml)

olympus ΕΜΠΟΡΙΑ ΙΑΤΡΙΚΩΝ ΕΙΔΩΝ ΜΟΝΟΠΡΟΣΩΠΗ ΙΔΙΩΤΙΚΗ ΚΕΦΑΛΑΙΟΥΧΙΚΗ ΕΤΑΙΡΕΙΑ Δ.Τ. olympus Λήμνου 5 & Θάσου, 142 35 Ν. Ιωνία 210.2821721 & 2711714 - loteprednol etabonate - ey.dro.sus (ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΕΝΑΙΩΡΗΜΑ) - 0,5% w/v (5mg/1ml) - loteprednol etabonate 5mg - loteprednol

LOTEMAX 0.5% EYE DROPS Cyprus - gréčtina - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

lotemax 0.5% eye drops

dr.gerhard mann chem.-pharm. fabrik gmbh (0000003416) brunsbutteler damm 165/173, berlin, 13581 - loteprednol etabonate - eye drops - 0.5% - loteprednol etabonate (8000002355) 5mg - loteprednol etabonate

ELYMBUS® EYE.GEL 0.1MG/G in single-dose container Grécko - gréčtina - Εθνικός Οργανισμός Φαρμάκων

elymbus® eye.gel 0.1mg/g in single-dose container

bimatoprost - eye.gel (ΟΦΘΑΛΜΙΚΗ ΓΕΛΗ) - 0.1mg/g in single-dose container - bimatoprost 0,1mg - bimatoprost

EVOREL 50MCG/24H TRANSDERMAL PATCH Cyprus - gréčtina - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

evorel 50mcg/24h transdermal patch

janssen-cilag international nv (0000003494) turnhoutseweg, 30, beerse, b-2340 - estradiol - transdermal patch - 50mcg/24h - estradiol (0000050282) 3.2mg - estradiol

ZOVIRAX 5% W/W CREAM Cyprus - gréčtina - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

zovirax 5% w/w cream

glaxosmithkline (ireland) limited (0000010774) 12 riverwalk, citywest business campus, dublin, dublin 24 - aciclovir - cream - 5% w/w - aciclovir (0059277893) 50mg - aciclovir

Volibris Európska únia - gréčtina - EMA (European Medicines Agency)

volibris

glaxosmithkline (ireland) limited - ambrisentan - Υπέρταση, πνευμονική - Αντιυπερτασικά, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

FENOBRAT CAPS 160MG/CAP Grécko - gréčtina - Εθνικός Οργανισμός Φαρμάκων

fenobrat caps 160mg/cap

bausch health ireland limited, ireland 3013 lake drive, d24ppt3 dublin 24 - fenofibrate - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 160mg/cap - fenofibrate 160mg - fenofibrate